• Adlai Nortye opens Boston Innovation Centre biospectrumasia
    August 21, 2018
    Adlai Nortye, a Hangzhou biopharma, has announced the opening of its first US site in Boston, Massachusetts. The Boston site was opened by CEO Carsten Lu, CDO Dr. Lars E. Bigerson, M.D., Ph.D. who is also President & CEO of Adlai Nortye USA Inc, and other
PharmaSources Customer Service